$GERN News

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron (GERN) Grants Inducement Stock Options to New Employees

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Geron Corporation (GERN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Geron (GERN)

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Geron: Time To Reconsider This Oversold Biotech

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026

Geron To Present Real-World Moffitt Cancer Center Study Showing RYTELO (imetelstat) Safety And Efficacy In Lower-Risk MDS At EHA 2026

Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?

A Look At Geron (GERN) Valuation After Q1 Results And Reaffirmed 2026 Guidance

Geron Corporation (NASDAQ:GERN) Just Reported And Analysts Have Been Lifting Their Price Targets

Geron Corporation Q1 2026 Earnings Call Summary

Geron Corporation (GERN) Q1 2026 Earnings Call Transcript

Geron Q1 Earnings Call Highlights

Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues